semaglutide visceral fat loss GLP-1 drugs are often framed as weight-loss drugs, but that perspective overlooks their deeper biology. Randomized trials show meaningful effects on cardiovascular events, fat, kidney health, and inflammation. already has Does Semaglutide Target Visceral Fat?

at the highest doses, gastrointestinal adverse events affected over 50% of participants, with most episodes mild to moderate

How to manage the balance Mothers who use GLP-1 therapy during breastfeeding (with physician approval) need a nutrition strategy that accounts for both the appetite-suppressing effects of the medication and the caloric demands of lactation

A., Hackett, J

Update: On a press briefing call earlier today, Dr

Some individuals may prefer the convenience of a once-weekly injection (Ozempic), while others may prefer a daily injection (Mounjaro)

Can potentially reduce the chance of developing obesity-related illnesses like heart disease and type 2 diabetes